Cellular immunity against Mycobacterium tuberculosis controls infection in the majority of infected humans. Studies in mice have delineated an important role for CD4+ T cells and cytokines including interferon γ and tumor necrosis factor α in the response to infection with mycobacteria. Recently, the identification of CD8+ CD1-restricted T cells that kill M. tuberculosis organisms via granulysin and the rapid death after infection of β2 microglobulin deficient mice in humans has drawn attention to a critical role for CD8+ T cells. The nature of mycobacterial-specific CD8+ T cells has been an enigma because few have been identified in any species. Here, we delineate the contribution of class I MHC–restricted T cells in the defense against tuberculosis as transporter associated with antigen processing (TAP)1-deficient mice died rapidly, bore a greater bacterial burden, and had more severe tissue pathology than control mice. In contrast, CD1D−/− mice were not significantly different in their susceptibility to infection than control mice. This data demonstrates a critical role for TAP-dependent peptide antigen presentation and provides further evidence that class I MHC–restricted CD8+ T cells, the major T cell subset activated by this antigen processing pathway, play an essential role in immunity to tuberculosis.
Skip Nav Destination
Article navigation
21 June 1999
Article|
June 21 1999
Susceptibility of Mice Deficient in CD1D or TAP1 to Infection with Mycobacterium tuberculosis
Samuel M. Behar,
Samuel M. Behar
From the *Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115; the ‡Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115; and the §Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Chicago, Illinois 60637
Search for other works by this author on:
Chris C. Dascher,
Chris C. Dascher
From the *Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115; the ‡Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115; and the §Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Chicago, Illinois 60637
Search for other works by this author on:
Michael J. Grusby,
Michael J. Grusby
From the *Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115; the ‡Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115; and the §Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Chicago, Illinois 60637
Search for other works by this author on:
Chyung-Ru Wang,
Chyung-Ru Wang
From the *Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115; the ‡Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115; and the §Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Chicago, Illinois 60637
Search for other works by this author on:
Michael B. Brenner
Michael B. Brenner
From the *Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115; the ‡Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115; and the §Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Chicago, Illinois 60637
Search for other works by this author on:
Samuel M. Behar
From the *Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115; the ‡Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115; and the §Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Chicago, Illinois 60637
Chris C. Dascher
From the *Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115; the ‡Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115; and the §Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Chicago, Illinois 60637
Michael J. Grusby
From the *Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115; the ‡Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115; and the §Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Chicago, Illinois 60637
Chyung-Ru Wang
From the *Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115; the ‡Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115; and the §Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Chicago, Illinois 60637
Michael B. Brenner
From the *Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115; the ‡Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115; and the §Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Chicago, Illinois 60637
Address correspondence to Samuel M. Behar, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Smith Bldg., Rm. 516C, 1 Jimmy Fund Way, Boston, MA 02115. Phone: 617-525-1033; Fax: 617-525-1010; E-mail: [email protected]
Received:
April 08 1999
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1999
J Exp Med (1999) 189 (12): 1973–1980.
Article history
Received:
April 08 1999
Citation
Samuel M. Behar, Chris C. Dascher, Michael J. Grusby, Chyung-Ru Wang, Michael B. Brenner; Susceptibility of Mice Deficient in CD1D or TAP1 to Infection with Mycobacterium tuberculosis . J Exp Med 21 June 1999; 189 (12): 1973–1980. doi: https://doi.org/10.1084/jem.189.12.1973
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement